Table 3: Outcomes and Therapies Received by 48 Patients Hospitalized for Legionnaire’s Disease.
Therapy |
Value no./no. total (%) |
Intravenous Fluids within 6 hours |
37/48 (77) |
Antibiotic Treatment within 6 hours |
31/48 (65) |
Antibiotic Treatment Levofloxacin with Azithromycin Levofloxacin alone Azithromycin alone |
40/48 (83) 5/48 (10) 3/48 (6) |
ICU admission |
19/48 (40) |
Respiratory Failure Requiring Invasive Mechanical Ventilation |
15/48 (31) |
Acute Respiratory Distress Syndrome [25] |
6/15 (40) |
Septic Shock [26] |
7/48 (15) |
Started on Renal Replacement Therapy |
2/46 (4) |
Hospital Mortality |
2/48 (4) |
ICU Mortality |
1/19 (2) |
Mean Interval from Onset of Symptoms to Death (n = 2) --- Days (Range) |
8 (7-9) |
Median Length of Hospital Stay --- Days (IQR) |
5 (3-12) |
Median Length of Mechanical Ventilation --- Days (IQR) |
5 (4-8) |